Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

S. Hiltbrunner,C. Britschgi, P. Schuberth, L. Bankel,T.D.L. Nguyen-Kim,P. Gulati, W. Weder,I. Opitz,O. Lauk, C. Caviezel, H. Bachmann, A. Tabor, P. Schröder,A. Knuth,C. Münz,R. Stahel,O. Boyman,C. Renner,U. Petrausch,A. Curioni-Fontecedro

Annals of Oncology(2021)

引用 39|浏览70
暂无评分
关键词
CAR T cells,clinical trial,fibroblast activation protein,immunotherapy,mesothelioma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要